Please find enclosed herewith copy of newspaper publication of extract of audited consolidated financial results for quarter and year ended March 31, 2026.
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Advanced Enzyme Technologies Ltd has published its audited consolidated financial results for Q4 and full year ended March 31, 2026. Total income from operations grew 17% to Rs 7,457.57 crore from Rs 6,369.10 crore in the previous year. Net profit after tax increased 30% to Rs 1,736.08 crore from Rs 1,339.74 crore. Total comprehensive income more than doubled to Rs 2,684.19 crore from Rs 1,527.96 crore. Basic EPS improved to Rs 15.08 from Rs 11.72, and diluted EPS to Rs 15.06 from Rs 11.71. The results were reviewed by the Audit Committee and approved by the Board on May 9, 2026, with statutory auditors issuing an unqualified report.
Strong financial performance with double-digit growth in revenue and significant profit expansion reflects healthy operational performance. The improved EPS and comprehensive income growth are positive indicators for shareholders.